Abcam Founder Ramps Up Board Seat Push at $4 Billion Biotech
- UK entrepreneur Milner holds discussions with other investors
- Milner is among Abcam’s largest shareholders with 6.4% stake
This article is for subscribers only.
UK entrepreneur Jonathan Milner is ramping up pressure on Abcam Plc to give him a board seat, as he seeks to improve performance at the biotechnology supplier he started 25 years ago.
Milner is seeking a nomination to Abcam’s board after the company’s annual general meeting on May 17, people familiar with the matter said. He’s held several discussions with other shareholders as well as Abcam directors, the people said, asking not to be identified as the matter is private.